Ignite Creation Date:
2024-05-06 @ 3:49 PM
Last Modification Date:
2024-10-26 @ 1:57 PM
Study NCT ID:
NCT04767594
Status:
RECRUITING
Last Update Posted:
2024-06-07
First Post:
2021-01-21
Brief Title:
First-line Palbociclib and Endocrine Therapy for Patients With HRHER2- Advanced Breast Cancer in the Real-world Setting
Sponsor:
Pfizer
Organization:
Pfizer
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Breast Neoplasms |
Keywords: